Delequamine

CAS No. 119905-05-4

Delequamine( —— )

Catalog No. M36152 CAS No. 119905-05-4

Delequamine (RS 15385-197) is a selective and potent TNIK inhibitor (IC50: 8 nM).TINK-IN-1 inhibits colorectal cancer cell viability and can be used to study mental retardation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 615 In Stock
10MG 873 In Stock
25MG 1311 In Stock
50MG 1730 In Stock
100MG 2316 In Stock
200MG Get Quote In Stock
500MG 4585 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Delequamine
  • Note
    Research use only, not for human use.
  • Brief Description
    Delequamine (RS 15385-197) is a selective and potent TNIK inhibitor (IC50: 8 nM).TINK-IN-1 inhibits colorectal cancer cell viability and can be used to study mental retardation.
  • Description
    Delequamine (RS 15385-197) is a selective and potent TNIK inhibitor (IC50: 8 nM).TINK-IN-1 inhibits colorectal cancer cell viability and can be used to study mental retardation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    119905-05-4
  • Formula Weight
    350.48
  • Molecular Formula
    C18H26N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(C)(=O)(=O)N1[C@]2(C[C@]3(C=4C(=CC(OC)=CC4)CCN3C[C@]2(CCC1)[H])[H])[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Guanfacine hydrochlo...

    A selective α2A receptor agonist that can reduce peripheral sympathetic outflow and thus cansues a reduction in peripheral sympathetic tone.

  • Cyclazosin HCl

    Cyclazosin HCl is a subtype-selective α-adrenergic receptor antagonist that competitively antagonizes norepinephrine-induced α(1B)-adrenergic receptor contraction and can be used to study non-arteritic ischemic optic neuropathy and other neurological diseases.

  • LY377604

    LY377604 is a human β3-adrenergic receptor agonist (EC50: 2.4 nM) and β1/2-adrenergic receptor antagonist for the study of obesity.